Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies
SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, an innovative subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), is thrilled to announce a strategic partnership with an intent to acquire BioSpark AI Technologies Inc., a Vancouver-based pioneer in advanced AI and large language model (LLM) technologies. Revealed today, this alliance is set to transform drug repurposing by leveraging cutting-edge AI to unlock transformative therapeutic insights from vast volumes of medical li
Article Link
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership
Pioneering a New Era in Healthcare: AI-Driven Innovation Unlocks Transformative Therapies and Drives Path to $50M ValuationSEATTLE, July 10, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, a wholly owned subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), in collaboration with premier academic institutions including Stanford University, Duke University, McMaster University (Canada), and global partners, proudly announces the successful completion of the REVIVE Adaptive Platform Trial (NCT0612
Article Link
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment
Company Targets OTCQB and NASDAQ Uplisting With Breakthroughs in Drug Repurposing, Functional Medicine, and Strategic AcquisitionsSEATTLE, July 08, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a Nevada-based pioneer in AI-driven drug repurposing and AI-driven functional medicine, today unveiled a transformative Game Plan to achieve a $50 million valuation and lead the $320.6 billion functional medicine market (CAGR 10.9%, Grand View Research). Powered by a dynamic manageme
Article Link
Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness
Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and WellnessMELBOURNE, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a leader in innovative technology and wellness solutions, is thrilled to announce that Michael Lawson has assumed the roles of Chief Executive Officer and Chairman of the Board, effective immediately. Mr. Lawson will also spearhead the newly established Fifty 1 Labs BioSentry Division, dedica
Article Link
UAV Corp. Drives Growth with Partnership, Dividend, New Leadership, and DART SA-70 Test Success
WEWAHITCHKA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- UAV Corp. (OTC: UMAV), a leader in UAV and airship technology, announces a strategic partnership with Fifty 1 Labs, Inc. (OTC: FITY), accelerating its mission to advance aerial surveillance and biohazard detection. This collaboration follows the successful DART SA-70 inflation test on April 24 and sets the stage for major growth. Shareholders will benefit from a planned FITY share dividend and the integration of FITY’s seasoned leadership tea
Article Link
|
